MIke Schmid / Flicker CC

Today, the Medicare Payment Advisory Commission will vote on whether Congress should make changes to Medicare Part B drug payments. And that explains why medical groups and the drug industry are foaming at the mouth with anger.

What's going on: MedPAC wants Congress to tinker with Medicare Part B, which currently pays the average sales price plus a 6% add-on for drugs administered in a physician's office or a hospital outpatient department. Instead, MedPAC recommended a host of different policies in March to cut spending, including mandated rebates from manufacturers to Medicare if prices rise above inflation and a new "drug value program" that encourages providers to negotiate on prices.

This is about money: Drugmakers and physicians have benefited immensely from Medicare Part B because the program guarantees a profit — and the higher the list price, the higher the profit. Most people realize the incentives are out of whack, but the pharmaceutical and medical industries will continue to torch any changes. Almost 200 medical societies and companies have already sent a letter to MedPAC asking it to kill its proposal.

Go deeper

Dave Lawler, author of World
18 mins ago - World

A hinge moment for America's role in the world

Photo illustration: Aïda Amer/Axios. Getty Images photo: Saul Loeb/AFP

The world may be living through the last gasps of America First — or just getting a taste of what's to come.

Why it matters: President Trump's message at this week's virtual UN General Assembly was short and relatively simple: global institutions like the World Health Organization are weak and beholden to China; international agreements like the Iran deal or Paris climate accord are "one-sided"; and the U.S. has accomplished more by going its own way.

New York daily coronavirus cases top 1,000 for first time since June

Photo: Chip Somodevilla/Getty Images

New York on Friday reported more than 1,000 new coronavirus cases for the first since June.

Why it matters: The New York City metropolitan area was seen as the epicenter of the COVID-19 pandemic throughout the spring. But strict social distancing and mask mandates helped quell the virus' spread, allowing the state to gradually reopen.

Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 2 p.m. ET: 32,647,382 — Total deaths: 990,473 — Total recoveries: 22,527,593Map.
  2. U.S.: Total confirmed cases as of 2 p.m. ET: 7,053,171 — Total deaths: 204,093 — Total recoveries: 2,727,335 — Total tests: 99,488,275Map.
  3. States: U.S. reports over 55,000 new coronavirus cases.
  4. Health: The long-term pain of the mental health pandemicFewer than 10% of Americans have coronavirus antibodies.
  5. Business: Millions start new businesses in time of coronavirus.
  6. Education: Summer college enrollment offers a glimpse of COVID-19's effect.